Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08719 | 32012315 | Biomed Chromatogr | Systematic investigation on the chemical basis of anti-NAFLD Qushi Huayu Fang. Part 1: A study of metabolic profiles in vivo and in vitro by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. | 2020 | Details |
| A08742 | 32003680 | Curr Pharm Des | Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities? | 2020 | Details |
| A08746 | 32002742 | Sleep Breath | Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08747 | 32002713 | Inflammation | Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD. | 2020 | Details |
| A08752 | 32000955 | J Am Coll Cardiol | Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. | 2020 | Details |
| A08754 | 32000567 | Adipocyte | Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. | 2020 | Details |
| A08760 | 31998283 | Front Immunol | Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. | 2020 | Details |
| A08761 | 31997561 | Liver Int | Collagen biology and non-invasive biomarkers of liver fibrosis. | 2020 | Details |
| A08765 | 31993304 | Acta Pharm Sin B | Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. | 2019 | Details |
| A08771 | 31991181 | Life Sci | Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08790 | 31982611 | Clin Gastroenterol Hepatol | Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08798 | 31981519 | Lancet Gastroenterol Hepatol | The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. | 2020 | Details |
| A08828 | 31975290 | Eur Radiol Exp | Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH). | 2020 | Details |
| A08855 | 31965018 | Sci Rep | Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice. | 2020 | Details |
| A08874 | 31954687 | Lancet Gastroenterol Hepatol | Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. | 2020 | Details |
| A08875 | 31954491 | J Hepatol | Advances in resection and transplantation for hepatocellular carcinoma. | 2020 | Details |
| A08897 | 31949229 | Sci Rep | Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. | 2020 | Details |
| A08899 | 31948298 | Expert Opin Investig Drugs | Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair. | 2020 | Details |
| A08924 | 31936026 | Nutrients | All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research. | 2020 | Details |
| A08940 | 31930271 | Food Funct | The preventive effect of phenolic-rich extracts from Chinese sumac fruits against nonalcoholic fatty liver disease in rats induced by a high-fat diet. | 2020 | Details |
| A08944 | 31929982 | Can J Gastroenterol Hepatol | Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic Individuals. | 2019 | Details |
| A08967 | 31921938 | Open Forum Infect Dis | Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016. | 2020 | Details |
| A09005 | 31907542 | Inflamm Bowel Dis | Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease. | 2020 | Details |
| A09010 | 31905444 | Ann Pediatr Endocrinol Metab | Application of body composition zones in boys with nonalcoholic fatty liver disease. | 2019 | Details |
| A09019 | 31902937 | Biol Pharm Bull | Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model. | 2020 | Details |
| A09028 | 31899128 | Ann Hepatol | Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. | 2019 | Details |
| A09035 | 31896166 | J Gastroenterol Hepatol | Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases. | 2020 | Details |
| A09062 | 31887451 | Clin Gastroenterol Hepatol | High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09068 | 31885733 | Dis Markers | Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09077 | 31883216 | Hepatol Res | Controlled attenuation parameter by vibration-controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging-based proton density fat fraction. | 2020 | Details |
| A09080 | 31882566 | Diabetes | The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH. | 2019 | Details |
| A09081 | 31882442 | Pharmacol Rev | Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease. | 2020 | Details |
| A09084 | 31881392 | Contemp Clin Trials | Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design. | 2019 | Details |
| A09093 | 31880002 | J Clin Lab Anal | Middle- and high-molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease. | 2019 | Details |
| A09096 | 31877771 | Cells | Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. | 2019 | Details |
| A09104 | 31873887 | Environ Sci Pollut Res Int | Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004. | 2019 | Details |
| A09105 | 31872499 | Liver Int | Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitis. | 2020 | Details |
| A09115 | 31868526 | Expert Opin Investig Drugs | Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A09127 | 31865317 | Dig Dis | Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. | 2019 | Details |
| A09134 | 31862486 | J Hepatol | Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09138 | 31861591 | J Clin Med | Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. | 2019 | Details |
| A09143 | 31860081 | Biosci Rep | Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A09146 | 31858523 | Histol Histopathol | Hepatocellular carcinoma in non-alcoholic fatty liver disease (NAFLD) - pathological evidence for a predominance of steatohepatitic inflammatory non-proliferative subtype. | 2019 | Details |
| A09153 | 31856189 | PLoS One | Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy. | 2019 | Details |
| A09155 | 31853866 | Obes Surg | Bariatric Surgery in Cirrhotic Patients: Is It Safe? | 2020 | Details |
| A09163 | 31852298 | Artif Cells Nanomed Biotechnol | Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease. | 2020 | Details |
| A09186 | 31843573 | J Ethnopharmacol | San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models. | 2019 | Details |
| A09208 | 31835362 | J Clin Med | Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09213 | 31834465 | Naunyn Schmiedebergs Arch Pharmacol | NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway. | 2019 | Details |
| A09238 | 31822978 | Eur Radiol | Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort. | 2019 | Details |
| A09246 | 31819566 | Diabetes Metab Syndr Obes | Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications. | 2019 | Details |
| A09267 | 31811953 | Clin Gastroenterol Hepatol | Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis. | 2019 | Details |
| A09279 | 31808236 | Hepatol Res | Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09288 | 31805015 | J Clin Invest | Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. | 2020 | Details |
| A09291 | 31803887 | Food Funct | The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD. | 2020 | Details |
| A09296 | 31801616 | J Transl Med | Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. | 2019 | Details |
| A09299 | 31800606 | PLoS One | ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population. | 2019 | Details |
| A09308 | 31796953 | Am J Clin Nutr | Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects. | 2020 | Details |
| A09331 | 31788461 | Front Pediatr | Progressive Liver Disease in Patients With Ataxia Telangiectasia. | 2019 | Details |
| A09342 | 31784293 | Arch Pediatr | Feeding problems and gastrointestinal diseases in Down syndrome. | 2019 | Details |
| A09347 | 31782595 | Liver Int | Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis. | 2019 | Details |
| A09361 | 31777896 | Food Funct | Attenuation of metabolic syndrome in the ob/ob mouse model by resistant starch intervention is dose dependent. | 2019 | Details |
| A09370 | 33778680 | Radiol Imaging Cancer | Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience. | 2019 | Details |
| A09377 | 31770380 | PLoS One | The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women. | 2019 | Details |
| A09414 | 31757736 | Presse Med | [What is the position of bariatric surgery in the treatment of non-alcoholic steatohepatitis?] | 2019 | Details |
| A09415 | 31757735 | Presse Med | [Pharmacological treatment of NASH]. | 2019 | Details |
| A09443 | 31746883 | Food Funct | Artemisia sphaerocephala Krasch polysaccharide prevents hepatic steatosis in high fructose-fed mice associated with changes in the gut microbiota. | 2019 | Details |
| A09451 | 31743810 | Nutrition | Phase angle as a severity indicator for liver diseases. | 2019 | Details |
| A09475 | 31730885 | Toxicol Lett | In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease. | 2019 | Details |
| A09476 | 31729980 | Lipids Health Dis | FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c. | 2019 | Details |
| A09480 | 31728041 | Sci Rep | Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism. | 2019 | Details |
| A09481 | 31727922 | Sci Rep | Fecal microbiome signatures of pancreatic cancer patients. | 2019 | Details |
| A09484 | 31726978 | BMC Genomics | Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. | 2019 | Details |
| A09495 | 31721770 | PLoS One | Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A09500 | 31718031 | Cancers (Basel) | A Role for the Biological Clock in Liver Cancer. | 2019 | Details |
| A09544 | 31701070 | Hepatol Commun | Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States. | 2019 | Details |
| A09551 | 31696774 | Gut Microbes | Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. | 2019 | Details |
| A09563 | 31693842 | Ultrasonography | Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. | 2019 | Details |
| A09566 | 31692556 | Diabetes Metab Syndr Obes | Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice. | 2019 | Details |
| A09567 | 31692530 | Pediatric Health Med Ther | Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management. | 2019 | Details |
| A09583 | 31686884 | Diabetes Metab Syndr Obes | Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide. | 2019 | Details |
| A09612 | 31675274 | Metab Syndr Relat Disord | Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection. | 2019 | Details |
| A09639 | 31665561 | Liver Transpl | Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. | 2020 | Details |
| A09657 | 31657145 | Pediatr Obes | Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease. | 2019 | Details |
| A09678 | 31651649 | Eur J Gastroenterol Hepatol | Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink. | 2020 | Details |
| A09679 | 31651571 | J Clin Gastroenterol | The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A09683 | 31650134 | Food Funct | Regulation effects of rosemary (Rosmarinus officinalis Linn.) on hepatic lipid metabolism in OA induced NAFLD rats. | 2019 | Details |
| A09695 | 31644993 | J Neurol Sci | Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke. | 2019 | Details |
| A09706 | 31638173 | Int J Mol Med | Role and mechanisms of action of microRNA‑21 as regards the regulation of the WNT/β‑catenin signaling pathway in the pathogenesis of non‑alcoholic fatty liver disease. | 2019 | Details |
| A09711 | 31637181 | J Transl Int Med | Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis Patient. | 2019 | Details |
| A09748 | 31627351 | Medicina (Kaunas) | Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease-A Cross Sectional Study. | 2019 | Details |
| A09762 | 31620647 | Transl Gastroenterol Hepatol | Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. | 2019 | Details |
| A09768 | 31617224 | Aliment Pharmacol Ther | Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres. | 2019 | Details |
| A09780 | 31613826 | Menopause | Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women. | 2020 | Details |
| A09804 | 31604107 | Life Sci | Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. | 2019 | Details |
| A09815 | 31599882 | Rev Invest Clin | INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, NON-ALCOHOLIC FATTY LIVER DISEASE, AND ITS RELATIONSHIP WITH FRUCTOSE CONSUMPTION IN CHILDREN WITH OBESITY. | 2019 | Details |
| A09824 | 31597900 | Nihon Yakurigaku Zasshi | [Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis]. | 2019 | Details |
| A09848 | 31592078 | Hepatol Commun | Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics. | 2019 | Details |
| A09854 | 31591263 | Mol Cell Proteomics | Absolute Quantification of Apolipoproteins Following Treatment with Omega-3 Carboxylic Acids and Fenofibrate Using a High Precision Stable Isotope-labeled Recombinant Protein Fragments Based SRM Assay. | 2019 | Details |
| A09867 | 31583739 | Aliment Pharmacol Ther | Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. | 2019 | Details |